Search

Your search keyword '"Growdon, John"' showing total 103 results

Search Constraints

Start Over You searched for: Author "Growdon, John" Remove constraint Author: "Growdon, John" Database Supplemental Index Remove constraint Database: Supplemental Index
103 results on '"Growdon, John"'

Search Results

2. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.

3. β-Glucocerebrosidase activity in -linked Parkinson disease: The type of mutation matters.

4. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease

5. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study

6. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study

7. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

8. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

9. Massachusetts Alzheimer's Disease Research Center: Progress and challenges.

11. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases

12. Rarity of the Alzheimer Disease–Protective APP A673T Variant in the United States

15. Novel Progranulin Mutation Detected in 2 Patients With FTLD.

16. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.

17. Effects of Simvastatin on Cholesterol Metabolism and Alzheimer Disease Biomarkers.

18. Long-term course and effectiveness of combination therapy in Alzheimer disease.

19. Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study

20. Unrecognized vitamin D3deficiency is common in Parkinson disease

21. A Phenotypic Change But Not Proliferation Underlies Glial Responses in Alzheimer Disease

22. Substantia Nigra Volume Loss Before Basal Forebrain Degeneration in Early Parkinson Disease

23. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

24. Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer's Disease

25. Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE GenotypesCR1, CLU, and PICALM as AD Susceptibility Loci

26. Cognitive–Behavioral Therapy for Patients With Parkinson’s Disease and Comorbid Major Depressive Disorder

27. Pattern of Depressive Symptoms in Parkinson's Disease

28. Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease

29. Molecular Imaging With Pittsburgh Compound B Confirmed at Autopsy: A Case Report

30. Influence of Heterozygosity for Parkin Mutation on Onset Age in Familial Parkinson Disease: The GenePD Study

31. Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease

32. The selective muscarinic M1 agonist AF102B decreases levels of total Aβ in cerebrospinal fluid of patients with Alzheimer's disease

33. The selective muscarinic M1 agonist AF102B decreases levels of total Aβ in cerebrospinal fluid of patients with Alzheimer's disease

36. Presenilin 1 Protein Directly Interacts with Bcl-2*

37. The effect of alcohol on essential tremor

38. Pupil Dilation to Tropicamide Is Not Specific for Alzheimer Disease

39. Association of Decreased Paternal Age and Late-Onset Alzheimer's Disease: An Example of Genetic Imprinting?

42. Unraveling the Mystery of Cognitive Changes in Old Age: Correlation of Neuropsychological Evaluation With Neuropathological Findings in the Extreme Old

43. A Model for Oral Dyskinesia in Rats

44. Postural changes tremor and myoclonus in the rat immediately following injections of pchloroamphetamine

45. CSF vasopressin concentration is reduced in Alzheimer's disease

46. Cognitive Test Performance in Detecting, Staging, and Tracking Alzheimer's Disease

47. Rate of Progression of Alzheimer's Disease Is Associated With Genetic Risk

48. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration

49. CSF somatostatinlike immunoreactivity in dementia

50. Vasopressin and Bradykinin Regulate Secretory Processing of the Amyloid Protein Precursor of Alzheimer's Disease

Catalog

Books, media, physical & digital resources